NICE u-turn on treatment for giant cell arteritis

8th March 2018 Uncategorised 0

Roche/Chugai’s RoActemra has now won the backing of the National Institute of Health and Care Excellence for the treatment of eligible patients with giant cell arteritis (GCA).

More: NICE u-turn on treatment for giant cell arteritis
Source: News